62 related articles for article (PubMed ID: 10958029)
1. WISDOM. Will Australian women participate?
MacLennan AH; Paine BJ; Marley JE
Aust Fam Physician; 2000 Aug; 29(8):797-801. PubMed ID: 10958029
[TBL] [Abstract][Full Text] [Related]
2. Associations between the use of complementary and alternative medications and demographic, health and lifestyle factors in mid-life Australian women.
Gollschewski S; Anderson D; Skerman H; Lyons-Wall P
Climacteric; 2005 Sep; 8(3):271-8. PubMed ID: 16390759
[TBL] [Abstract][Full Text] [Related]
3. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
4. What is WISDOM and why should Australia participate?
Murkies A
Aust Fam Physician; 2000 Aug; 29(8):796. PubMed ID: 10958028
[No Abstract] [Full Text] [Related]
5. Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757].
Veerus P; Hovi SL; Fischer K; Rahu M; Hakama M; Hemminki E
Maturitas; 2006 Sep; 55(2):162-73. PubMed ID: 16504428
[TBL] [Abstract][Full Text] [Related]
6. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
7. Special populations recruitment for the Women's Health Initiative: successes and limitations.
Fouad MN; Corbie-Smith G; Curb D; Howard BV; Mouton C; Simon M; Talavera G; Thompson J; Wang CY; White C; Young R
Control Clin Trials; 2004 Aug; 25(4):335-52. PubMed ID: 15296809
[TBL] [Abstract][Full Text] [Related]
8. Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women.
Panjari M; Bell R; Adams J; Morrow C; Papalia MA; Astbury J; Davis SR
J Womens Health (Larchmt); 2008 Dec; 17(10):1559-65. PubMed ID: 19000028
[TBL] [Abstract][Full Text] [Related]
9. [Menopause, hormone therapy and self-rated health. A cross-sectional study in Roskilde county in 1998].
Søndergaard KM; Hindsberger C; Toft U; Adser L; Damsgaard JJ; Hvas AC
Ugeskr Laeger; 2005 Aug; 167(34):3180-4. PubMed ID: 16117918
[TBL] [Abstract][Full Text] [Related]
10. Cross-cultural comparisons of health-related quality of life in Australian and Japanese midlife women: the Australian and Japanese Midlife Women's Health Study.
Anderson DJ; Yoshizawa T
Menopause; 2007; 14(4):697-707. PubMed ID: 17438514
[TBL] [Abstract][Full Text] [Related]
11. The menopause symptom profile of Maori and non-Maori women in New Zealand.
Lawton BA; Rose SB; Cormack DM; Stanley J; Dowell AC
Climacteric; 2008; 11(6):467-74. PubMed ID: 18802815
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy use over a decade in an Australian population.
MacLennan AH; Wilson DH; Taylor AW
Climacteric; 2002 Dec; 5(4):351-6. PubMed ID: 12626214
[TBL] [Abstract][Full Text] [Related]
13. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
Lucas R; Barros H
Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
[TBL] [Abstract][Full Text] [Related]
14. The 2003 Australian Breast Health Survey: survey design and preliminary results.
Villanueva EV; Jones S; Nehill C; Favelle S; Steel D; Iverson D; Zorbas H
BMC Public Health; 2008 Jan; 8():13. PubMed ID: 18194528
[TBL] [Abstract][Full Text] [Related]
15. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
[TBL] [Abstract][Full Text] [Related]
16. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.
Almeida OP; Lautenschlager NT; Vasikaran S; Leedman P; Gelavis A; Flicker L
Neurobiol Aging; 2006 Jan; 27(1):141-9. PubMed ID: 16298249
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and correlates of hormonal therapy among Israeli women in the post-WHI era.
Keinan-Boker L; Dictiar R; Garty N; Green MS
Maturitas; 2005; 52(3-4):364-73. PubMed ID: 16043316
[TBL] [Abstract][Full Text] [Related]
18. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
19. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
20. The perception of menopause and hormone therapy among women in Turkey.
Uncu Y; Alper Z; Ozdemir H; Bilgel N; Uncu G
Climacteric; 2007 Feb; 10(1):63-71. PubMed ID: 17364606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
